What are the odds of ear barotrauma or a ruptured eardrum from flying with a cold?
Evidence quality 4.5/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 4/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 3/5
- D8 Caveat completeness
- 5/5
Lifetime probability · lifetime, activity-specific
1 in 2.9
34% lifetime chance
range 1 in 6.7 to 1 in 1.7
● your factors — click this risk ▾ to reveal
≈ As likely as
Perceived
Flying with a head cold is one of the more durable pieces of folk-medicine anxiety — most people who have ever had an ear "pop and stay popped" on descent will tell the story for years, and aviation crews are loudly warned off the flight deck while sick. The intuition is that flying congested is meaningfully risky, probably around 1 in 20 to 1 in 3 of ending a flight with a sore ear, and a small but non-trivial chance of actual tympanic-membrane damage. That intuition is unusually close to what the aviation-medicine literature finds, which makes this one of the few folk fears that survives a look at the numbers roughly intact. We have not found a standalone survey isolating "fear of flying congested", so perceived risk is marked as editorial intuition.
Rough estimate: most travelers guess 1 in 20 to 1 in 3 per flight for 'meaningful' ear pain when flying with a cold
Source: editorial intuition, not polled
Actual
~1 in 3 per flight for moderate-or-worse ear barotrauma when flying with an active URI
adult commercial-aviation passengers flying with an active upper-respiratory infection
Show derivation
Scope is activity_specific_lifetime and the headline is a per-flight probability, not a population-lifetime accumulation. Baseline per-flight ear-pain rate in healthy adults sits around 10-20 percent (Stangerup/Klokker prevalence studies summarised in Wright's BMJ Clinical Evidence review: "20% of adult and 40% of child passengers had negative pressure in the middle ear after flight, and 10% of adults and 22% of children had otoscopic evidence of changes to the ear drum"). In the Csortan/Jones placebo arm of 250 adult passengers with a history of recurrent ear discomfort, 62 percent of controls reported some ear pain per flight; Wright's review cites a separate placebo arm where 29/41 (71 percent) of adults had barotrauma symptoms without pseudoephedrine. When a traveler is actively congested with a URI, the pre-flight pilot survey (Rosenkvist et al. 2008, 948 commercial pilots) found 37.6 percent had experienced at least one ear-barotrauma episode in their career, with 90 percent of those events on descent — and pilots pre-select strongly for healthy Eustachian-tube function. The headline "roughly 1 in 3 per URI-flight for moderate-or- worse barotrauma" is the midpoint of (a) the 62-71 percent any-symptom rate in predisposed placebo arms and (b) the ~10-20 percent objective-finding rate in unselected passengers, triangulated against the pilot-survey career rate. Tympanic- membrane perforation is a much rarer outcome: Wright's review states plainly that perforation rates are "not reported" in the commercial-aviation literature and are "extremely rare"; the order-of-magnitude estimate from case-series and aviation- medicine textbooks is roughly 1 per 1,000 to 1 per 10,000 URI-flights, captured in the regional_breakdown rather than the headline.
Caveats: The headline "roughly 1 in 3 per flight" applies to adult commercial passengers …
The headline "roughly 1 in 3 per flight" applies to adult commercial passengers with active symptomatic upper-respiratory infection and moderate-or-worse otic barotrauma — pain that outlasts the flight, temporary conductive hearing loss, or Teed grade ≥2 otoscopic findings. It is not a rate of tympanic-membrane perforation, which is roughly two to three orders of magnitude rarer (~1 in 1,000 to ~1 in 10,000 URI-flights) and is captured in the regional_breakdown. The figure also assumes a standard commercial descent profile in a pressurised Part 121 airliner; rapid descents, unpressurised general aviation, and combat or EMS aviation are a different regime. Descent is the dominant phase of risk (roughly 90 percent of Rosenkvist's pilot cohort's barotrauma events), so "the flight" is really "the last twenty minutes of the flight". Oral pseudoephedrine and topical oxymetazoline before descent each cut the symptomatic rate by roughly half in adults in randomised trials, but neither eliminates risk, and pseudoephedrine has not been shown to help children. Finally, the underlying literature is heterogeneous on outcome definition: some studies count any negative middle-ear pressure on post-flight tympanometry, others count only patient-reported pain, and the three trials of decongestant prophylaxis use three different symptom scales. The 15-60 percent uncertainty range reflects that mixture honestly rather than hiding it.
Regional breakdown
The headline figure averages across very different populations. Here’s how the probability varies by geography or context:
| Region / context | Lifetime probability | Notes |
|---|---|---|
| Per flight, adult with active URI (any ear symptoms) | 1 in 1.7 |
Upper end of the range — closer to the 71 percent placebo-arm figure from the pseudoephedrine RCTs for adults with a history of recurrent ear pain. Captures the 'ear hurt enough to notice' outcome, not the 'clinically significant barotrauma' outcome. |
| Per flight, adult with active URI (moderate or worse barotrauma) | 1 in 2.9 |
Headline number. Triangulated from placebo-arm symptom rates in predisposed flyers, objective otoscopic-change rates after flight, and the descent-dominant Rosenkvist career data. Moderate-or-worse means pain lasting beyond landing, temporary conductive hearing loss, or a Teed grade ≥2 otoscopic finding. |
| Per flight, general-population adult (no URI) | 1 in 6.7 |
Baseline passenger rate for any ear discomfort. Objective tympanic-membrane changes on post-flight otoscopy sit closer to 10 percent in unselected adults; this row conflates subjective pain and objective findings at the upper end of that range. |
| Per flight, adult with URI on descent specifically | 1 in 3.3 |
Descent is where essentially all clinically significant barotrauma originates — the Rosenkvist pilot survey attributed 90 percent of career ear-barotrauma events to descent. Pressure changes during ascent are dominated by active Eustachian-tube venting, which a congested tube can still manage; descent requires the tube to open against a pressure differential, which it often cannot. |
| Per flight, child with URI | 1 in 1.8 |
Upper end of the 26-55 percent pediatric ear-pain rate cited in post-flight otoscopy studies, adjusted upward for active URI. Smaller Eustachian tubes plus higher URI prevalence compound; pseudoephedrine has not been shown to help in children. |
| Per flight, adult with URI taking oral pseudoephedrine 30+ minutes pre-flight | 1 in 5.9 |
The pseudoephedrine RCT midpoint: roughly half the placebo rate in predisposed adults (34% active vs 71% placebo in the Wright BMJ review; 32% active vs 62% placebo in Csortan/Jones 1994). Topical oxymetazoline before descent has a similar effect size. Decongestants reduce the rate meaningfully but do not eliminate it. |
| Per flight, adult with URI — tympanic-membrane perforation | 1 in 2,000 |
Order-of-magnitude estimate. Wright's BMJ review states perforation rates are 'not reported' and 'extremely rare' in commercial aviation; aviation-medicine case series suggest roughly 1 per 1,000 to 1 per 10,000 URI-flights, with the higher end applying to severe URI plus aggressive descent (combat aviation, rapid depressurisation). TM perforation is a small fraction of the clinically significant-barotrauma denominator. |
Risks at similar odds
Other risks with roughly the same likelihood — useful for calibration.
Travelers' diarrhea
What are the odds of getting travelers' diarrhea on an international trip to a high-risk destination?
Adventure sports
What are the odds of a serious injury from regular participation in surfing, mountain biking, or rock climbing?
Drug-resistant infection
What is the risk of developing a serious antibiotic-resistant infection?
Recently viewed on this device
Stored locally — clear anytime.
Pick challenger
The aviation-medicine literature is unusually consistent on this one. Adult passengers flying healthy have roughly a 10 to 20 percent chance per flight of any measurable ear trouble — a post-flight tympanogram showing negative middle-ear pressure, or the sort of ear pain that makes you chew gum harder on descent. Adult passengers flying with an active upper-respiratory infection move into a different regime: the placebo arms of the two randomised decongestant trials found 62 to 71 percent of predisposed adults had symptomatic ear pain per flight, and Rosenkvist’s survey of 948 Danish commercial pilots (a population pre-screened for normal Eustachian-tube function) found 37.6 percent had experienced at least one career ear-barotrauma event, with 90 percent of those events on descent. Triangulating across those sources, a reasonable headline for the specific question “will my ears really hurt if I fly with this cold” is roughly 1 in 3 per flight for moderate-or-worse barotrauma, with the full “any ear symptoms” rate pushing toward 3 in 5. Actual tympanic-membrane perforation is rarer by two to three orders of magnitude, somewhere between 1 in 1,000 and 1 in 10,000 URI-flights, and almost always happens on descent.
What is interesting is that this is one of the few folk fears that survives the numbers roughly intact. The mechanism is textbook ENT: the middle ear is a sealed gas-filled cavity whose only pressure-equalising path is the Eustachian tube; cabin pressure rises by roughly a quarter of an atmosphere during a typical descent; a tube swollen by viral rhinitis cannot open against that pressure differential and the tympanic membrane bows inward until something gives. Randomised trials of oral pseudoephedrine and topical oxymetazoline before flight each cut the symptomatic rate by roughly half in adults, not to zero. Pseudoephedrine has not been shown to help in children, whose Eustachian tubes are shorter, more horizontal, and harder to open under pressure to begin with. The Merck Manual’s straightforward clinical line, “a person with nasal congestion due to an upper respiratory infection or allergies should avoid flying,” is not precautionary hedging; it is the empirical position of the literature.
The number does not transfer cleanly. Descent is essentially the entire risk window, so a flight that ends with a very gradual pressurisation schedule is a different exposure from one ending in a rapid commercial descent into a coastal airport. Children with URI run roughly 1.5 to 2 times the adult URI rate, and do not benefit from the standard adult decongestant workaround. Adults with a prior tympanic-membrane perforation history, with bullous myringitis, with recent SCUBA exposure, or with established Eustachian-tube dysfunction sit at a meaningfully elevated baseline even without a URI. And the literature’s outcome definitions are a quiet mess — some studies count any post-flight tympanogram abnormality, others count only patient-reported pain, and a few count only clinician-graded otoscopic findings; so the 15-60 percent uncertainty band on the headline is not a rhetorical hedge but an accurate reflection of how the underlying evidence is actually structured.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] Journal of Laryngology & Otology (Mirza S, Richardson H) — Otic barotrauma from air travel
Otic barotrauma from air travelSee all 2 Likelier entries citing this source →
- Statistic
Otic barotrauma is a common problem in air travellers; middle-ear pressure changes during descent are the dominant mechanism; topical and oral decongestants are the main evidence-based prophylaxis with modest effect sizes in randomised trials- Excerpt
“"Otic barotrauma occurring during air travel involves traumatic inflammation of the middle ear, caused by a pressure difference between the air in the middle ear and the external atmosphere, developing after ascent or more usually descent." ”
- Source data from
- 2005-05-01
- Accessed
- 2026-04-16 · archived copy
- Calculation
- Mirza & Richardson is the canonical narrative review of air-travel otic barotrauma, published in J Laryngol Otol 119(5):366-70. The paper does not supply a single headline incidence figure — it summarises the fragmentary passenger and aircrew epidemiology and the three randomised decongestant trials available at the time — so we use it as the mechanistic and methodological anchor, not the quantitative anchor. The paper's core clinical claim, that a blocked Eustachian tube cannot equilibrate cabin-pressure changes during descent and that this is the direct mechanism of barotrauma, is the foundation for the "URI flight = higher rate" step in the native calculation. The 10-20 percent baseline adult rate and the 26-55 percent child rate cited in the Native field trace back through this review to Stangerup, Klokker, Csortan/Jones, and the Tonkin/Fagan series.
- Independence
- Mirza & Richardson synthesise the Stangerup auto-inflation trials and the Csortan/Jones pseudoephedrine RCT; treat it as an editorially independent review of primary data that overlaps methodologically with both the Wright BMJ review and the Rosenkvist pilot survey cited below.
-
[2] BMJ Clinical Evidence (Wright T) — Middle-ear pain and trauma during air travel
Middle-ear pain and trauma during air travel- Statistic
20% of adult and 40% of child passengers had negative middle-ear pressure after flight; 10% of adults and 22% of children had otoscopic evidence of tympanic-membrane changes; pseudoephedrine reduced adult barotrauma from 29/41 (71%) placebo to 14/41 (34%) active (RR 0.48, 95% CI 0.29-0.67); pseudoephedrine ineffective in children- Excerpt
“"20% of adult and 40% of child passengers had negative pressure in the middle ear after flight, and that 10% of adults and 22% of children had otoscopic evidence of changes to the ear drum. ... 14/41 (34%) with oral pseudoephedrine ... 29/41 (71%) with placebo (RR 0.48, 95% CI 0.29 to 0.67)." ”
- Source data from
- 2015-01-19
- Accessed
- 2026-04-16 · archived copy
- Calculation
- Wright's BMJ Clinical Evidence review (PMC4298289) is the single densest public source of per-flight prevalence numbers. The 10-20 percent adult rate of objective tympanic-membrane changes per flight is the baseline used in the Native field. The pseudoephedrine RCT numbers are used twice: the 71 percent placebo rate in adults prone to ear pain is the upper end of the "any symptom" per-flight probability for predisposed flyers, which brackets the URI-flight regime; the 34 percent pseudoephedrine rate sets the "decongestant pre-flight" multiplier in personal_factor_multipliers (roughly 0.5x the symptomatic rate, not zero). The pediatric ineffectiveness of pseudoephedrine and the 40 percent pediatric post-flight negative-pressure rate anchor the "children with URI" row in regional_breakdown.
- Independence
- Wright's review cites the Csortan/Jones 1994 Annals of Emergency Medicine RCT and Stangerup's auto-inflation trials, overlapping with Mirza & Richardson on primary sources. The two authoritative reviews are not fully independent on inputs but reach convergent numeric ranges, which raises confidence in the order-of-magnitude estimates used here.
-
[3] Aviation, Space, and Environmental Medicine (Rosenkvist L, Klokker M, Katholm M) — Upper respiratory infections and barotraumas in commercial pilots: a retrospective survey
Upper respiratory infections and barotraumas in commercial pilots: a retrospective survey- Statistic
948 Danish commercial pilots surveyed; 37.6% reported one or more ear-barotrauma episodes in their career; 90% of ear-barotrauma events occurred during descent; 19.5% reported sinus barotrauma; 42.8% continued flying despite URI symptoms; 78.0% of those who flew used decongestants; 57.2% self-assessed as unfit to fly with URI- Excerpt
“"Ear barotrauma was reported by 37.6% of the pilots. Ninety percent of the ear barotraumas were reported during descent. ... 42.8% continued flying duties despite URI symptoms; 78.0% of those who flew used decongestants." ”
- Source data from
- 2008-10-01
- Accessed
- 2026-04-16 · archived copy
- Calculation
- Rosenkvist et al. is the single study that directly couples URI prevalence with in-career barotrauma prevalence in a well-defined flying population. One third of Denmark's commercial pilots — a population pre-screened for normal Eustachian-tube function — reported at least one ear-barotrauma episode across a career of thousands of flights, with 90 percent of those episodes on descent. This anchors two things: (1) descent as the dominant phase of risk, used throughout the regional_breakdown and caveats; (2) the "URI flight is categorically different from a healthy flight" framing, since nearly half the cohort admitted flying with URI symptoms and the in-career barotrauma rate is orders of magnitude above the per-flight baseline. The pilot career rate is not directly convertible to a per-URI-flight probability without knowing the URI-flight fraction of the career, but it corroborates the order of magnitude of the headline.
- Independence
- Rosenkvist is fully independent of Mirza & Richardson and of Wright — different country, different population (active airline pilots vs passengers), different data source (retrospective self-report vs post-flight otoscopy). The three authoritative sources on this page converge from three methodological directions.
-
[4] Merck Manual Professional Edition (Jan TA, reviewed by Lustig LR) — Otic Barotrauma
Otic Barotrauma- Statistic
A person with nasal congestion due to an upper respiratory infection or allergies should avoid flying; topical nasal vasoconstrictor (phenylephrine, oxymetazoline) applied 30-60 minutes before descent is the standard prophylaxis when flight is unavoidable- Excerpt
“"When an upper respiratory infection, allergy, or other mechanism interferes with eustachian tube function during changes in environmental pressure, the pressure in the middle ear either falls below ambient pressure. ... A person with nasal congestion due to an upper respiratory infection or allergies should avoid flying and diving. ... When these activities are unavoidable, a topical nasal vasoconstrictor (eg, phenylephrine, oxymetazoline) is applied 30 to 60 minutes before descent and ascent." ”
- Source data from
- 2024-01-01
- Accessed
- 2026-04-16 · archived copy
- Calculation
- The Merck Manual Professional entry supplies the standard-of-care clinical frame: URI is a recognised contraindication to flying; descent is the dangerous phase; topical decongestant pre-descent is the evidence-based mitigation. Used as a reputable clinical reference anchoring the mechanism and the mitigation language rather than a primary quantitative source, since Merck does not publish a headline incidence figure.
- Independence
- Merck Manual editorial reviews are independent of the three primary-literature sources above and draw on a wider clinical evidence base, but the synthesis points at the same RCTs and reviews, so treat as corroborating rather than as an independent measurement.